90Y PET-based dosimetry after selective internal radiotherapy treatments

Nuclear Medicine Communications

Volumn 33, Issue 6, 2012, Pages 633-640

  D'Arienzo, Marco ^a,b   Chiaramida, Paola ^d   Chiacchiararelli, Laura ^a   Coniglio, Angela ^c   Cianni, Roberto ^e   Salvatori, Rita ^e   Ruzza, Alberto ^e   Scopinaro, Francesco ^a   Bagni, Oreste ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ENEA C R CASACCIA   (Italy)

^c SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^d GE HEALTHCARE   (United Kingdom)

^e SANTA MARIA GORETTI HOSPITAL   (Italy)

Author keywords

90Y positron emission tomography imaging; microspheres; radioembolization; radionuclide therapy; selective internal radiotherapy; voxel dosimetry

Indexed keywords

BISMUTH DERIVATIVE; FLUORODEOXYGLUCOSE F 18; RADIOACTIVE MICROSPHERE; TECHNETIUM 99M; YTTRIUM 90; DIAGNOSTIC AGENT; MICROSPHERE; YTTRIUM;

ALGORITHM; ARTICLE; CANCER RADIOTHERAPY; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DOSE CALCULATION; DOSIMETRY; FEASIBILITY STUDY; HISTOGRAM; HUMAN; IMAGE ANALYSIS; MONTE CARLO METHOD; PHANTOM; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE DISTRIBUTION; RADIOTHERAPY; IMAGE QUALITY; LIVER; LIVER TUMOR; METABOLISM; METHODOLOGY; RADIATION DOSE; RADIOMETRY; SCINTISCANNING; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

ALGORITHMS; FEASIBILITY STUDIES; HUMANS; LIVER; LIVER NEOPLASMS; MICROSPHERES; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOMETRY; RADIOTHERAPY DOSAGE; TISSUE DISTRIBUTION; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84860836535     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283524220     Document Type: Article

References (26)

1. Lau WY, Ho S, Leung TW, Chan M, Ho R, Johnson PJ, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 1998; 40:583-592. (Pubitemid 28104228)
2. Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, et al. Randomized trial of SIR-spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001; 12:1711-1720. (Pubitemid 34105661)
3. Salem R, Thurston KG, Carr BI, Goin JE, Geschwind J-FH. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002; 13:S223-S229.
4. 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 2005; 16:1627-1639. (Pubitemid 44431160)
5. Sharma RA, Van Hazel GA, Morgan B, Berry DP, Blanshard K, Price D, et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007; 25:1099-1106. (Pubitemid 46596762)
6. 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 2009; 74:1494-1500.
7. Ackerman NB, Lien WM, Kondi ES, Silverman NA. The blood supply of experimental liver metastasis I: the distribution of hepatic artery and portal vein blood to 'small' and 'large' tumors. Surgery 1970; 66:1067-1072.
8. 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations. J Nucl Med 2006; 47:1209-1211. (Pubitemid 47544917)
9. Flamen P, Vanderlinde B, Delatte P, Ghanem G, Ameye L, Van Den Eynde M, et al. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with yttrium-90 labeled resin micropheres. Phys Med Biol 2008; 53:6591-6603.
10. Sarfaraz M, Kennedy AS, Lodge MA, Li AX, Wu X, Yu CX. Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma. Med Phys 2004; 31:2449-2453. (Pubitemid 39287858)
11. 90Y microsphere hepatic radioembolization in metastatic tumors. J Nucl Med Radiat Ther 2011; 2:111.
12. 90Y SIR spheres: radiobiologic considerations. J Nucl Med 2010; 51:1377-1385.
13. 90Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization. Eur J Nucl Med Mol Imaging 2011; 38:1281-1288.
14. 90Y therapy of liver cancer. Technol Cancer Res Treat 2010; 9:253-262.
15. 90. Phys Rev 1955; 98:1516-1517.
16. 90Sr. Appl Radiat Isot 2007; 65: 318-327. (Pubitemid 44960818)
17. Nickles RJ, Roberts AD, Nye JA, Converse AK, Barnhart TE, Avila-Rodirguez MA. Assaying and PET imaging of yttrium-90: l < 34 ppm< 0. IEEE Nucl Sci Symp Rec 2004; 6:3412-3414. (Pubitemid 41147680)
18. Lhommel R, Goffette P, Van den Eynde M, Jamar F, Pauwels S, Bilbao J, et al. Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging 2009; 36:1696.
19. 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. Eur J Nucl Med Mol Imaging 2010; 37:1654-1662.
20. 90Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases. Eur J Nucl Med Mol Imaging 2010; 37:407-408.
21. 90Y permits hepatic localization of microspheres using routine PET: proof of concept. J Nucl Med 2011; 52:72-76.
22. 90Y PET for the assessment of microsphere biodistribution after selective internal radiotherapy (SIRT). Nucl Med Commun 2012; 33:198-204.
23. National Electrical Manufacturers Association (NEMA). Performance Measurements of Positron Emission Tomographs, NEMA NU 2-2007.
24. Cristy M, Eckerman K. Specific absorbed fractions of energy at various ages from internal photons sources. Health and Safety Research Division, ORNL/TM-8381 V1-V7, 1987.
25. 90Y PET. J Nucl Med 2010; 51:1969-1973.
26. Van Elmbt L, Vandenberghe S, Walrand S, Pauwels S, Jamar F. Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy. Phys Med Biol 2011; 56: 6759-6777.